Page 7 - Pharma Sctors
Natco board approves proposal to acquire US-based pharma company
The company's board has approved to acquire Dash Pharmaceuticals through one of its subsidiary units, it said
 "Natco board approves proposal to acquire US-based pharma company")
AstraZeneca blocks Advent's $7.6-bn buyout of Swedish Orphan Biovitrum
The UK drugmaker's opposition meant the offer fell short of the 90 per cent threshold needed for approval
 "AstraZeneca blocks Advent's $7.6-bn buyout of Swedish Orphan Biovitrum")
Pharma stocks rally on buzz about new Covid variant, travel stocks sink
Huge gains for Cipla, Alkem Labs and Dr Lal Path, even as IndiGo, Chalet Hotels and IHC tank
 "Pharma stocks rally on buzz about new Covid variant, travel stocks sink")
BSE Healthcare index up 2%; Cipla, Alkem, Dr.Reddy's rally up to 8%
The pharma index had taken a breather over the past three months after displaying relative out-performance during CY20-21.
 "BSE Healthcare index up 2%; Cipla, Alkem, Dr.Reddy's rally up to 8%")
Cabinet secy-led panel to take call on more allocation to PLI pharma
The department has urged the top government panel to provide additional funds of around Rs 3,000 crore under the scheme for pharmaceutical medicines
 "Cabinet secy-led panel to take call on more allocation to PLI pharma")
Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
The drug firm on Monday reported a decline in its consolidated net profit
 "Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore")
This SME pharma stock has zoomed 108% thus far in September
In past three months, Kwality Pharmaceuticals has zoomed 398 per cent, as compared to 12.8 per cent rise in the S&P BSE Sensex on the back of improved business outlook
 "This SME pharma stock has zoomed 108% thus far in September")
ACC, Cipla: 66 stocks from Nifty 500 index are showing weakness on charts
Few pharma stocks are expected to weaken at higher levels.
 "ACC, Cipla: 66 stocks from Nifty 500 index are showing weakness on charts")
Alembic Pharma sees domestic business growing in double digits this fiscal
Strong brand recall, an efficient sales force, a growing network of supportive doctors and timely product launches are the key catalysts for this business
 "Alembic Pharma sees domestic business growing in double digits this fiscal")
Fortis Malar, Lal Path Labs: Diagnostic and healthcare stocks on the charts
Stocks of diagnostic chains and hospitals have been in focus as Covid-19 pandemic spread across the country. Is it a good strategy to stay put in these counters? Here's what the charts suggest
 "Fortis Malar, Lal Path Labs: Diagnostic and healthcare stocks on the charts")
India may face shortage of drugs as supplies from Chinese companies dry up
Almost 60% of India's total bulk drug requirements are imported from China
 "India may face shortage of drugs as supplies from Chinese companies dry up")